WHO WE ARE

Management Team & Advisory Board

External Review Board

  • Peter Young, MBA

    Executive-in-Residence, Pappas Ventures

  • Anton Xavier

    Senior Scientist & Scout, Pfizer

  • Jessica Swartz, PhD

    Sr. Director, Strategy Planning, Pfizer Essential Health
    Pfizer

  • Tara Sharif, PhD

    Managing Director WestPark Capital, Inc.

  • Barbara Sawitsky

    Director of Patents and Licensing, New York Blood Center

  • Jeffrey Saelens, PhD

    Interim Executive Director, Long Island High Technology Incubator

  • Christopher M. Moxham, PhD

    Vice President, Quantitative Biology, Eli Lilly and Company

  • Gregory Montalbano

    Principal, MIDI Medical Product Development

  • Christopher Montalbano

    Principal, MIDI Medical Product Development

  • Michael E. Marino, PhD

    Manager, General Electric Corporation – Global Research Center

  • Sathapana (Sam) Kongsamut, PhD

    President, Rudder Serendip LLC.

  • Kevin Koch, PhD

    Venture Partner, OrbiMed

  • Thomas D. Ippolito

    Vice President, Clinical and Regulatory Affairs, Chembio Diagnostic Systems, Inc.

  • Kenton C. Hasson, PhD

    Sr Manager, Business Development and Innovation, Canon US Life Sciences

  • John D. Haley, PhD

    Associate Professor, Pathology, Stony Brook University; Director, Developmental Therapeutics, Stony Brook Cancer Center; Director, Stony Brook University Proteomics Center

  • Andreas Grill, MS, MBA

    President and CEO, DepYMed

  • Colleen Cuffaro, PhD

    Associate, Cannan Partners

  • Bruce Conway, PhD

    Program Director, Robertson Therapeutic Development Fund, The Rockefeller University